Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Brand name Active drug Indication Approval year Max approved dose Ozempic Semaglutide Type 2 diabetes (glycemic control) 2017 2 mg/week Wegovy Semaglutide Chronic weight management (BMI 30 or 27 + comorbidity) 2021 2.4 mg/week Rybelsus Semaglutide Type 2 diabetes (oral daily tablet) 2019 14 mg/day (oral) Mounjaro Tirzepatide Type 2 diabetes (glycemic control) 2022 15 mg/week Zepbound Tirzepatide Chronic weight management (BMI 30 or 27 + comorbidity) 2023 15 mg/week Table 1 FDA-approved indications for semaglutide and tirzepatide brand names
You might feel a dull throb at the site for several hours or even a day or two
Pre-measured doses remove the guesswork, making them simple to include in a daily routine
10.1186/s12943-018-0796-y 129 ZhangZ.KongY.YangW.MaF.ZhangY.JiS.et al
